Phase 2 study of afatinib among patients with recurrent and/or metastatic esophageal squamous cell carcinoma.
Hong MH, Heo SG, Lee YG, Kim HS, Park KU, Kim HG, Ko YH, Chung IJ, Min YJ, Kim MK, Kim KR, Yoo J, Kim TM, Kim HR, Cho BC.
Hong MH, et al. Among authors: kim hg, kim kr, kim tm, kim hr, kim hs, kim mk.
Cancer. 2020 Oct 15;126(20):4521-4531. doi: 10.1002/cncr.33123. Epub 2020 Aug 4.
Cancer. 2020.
PMID: 32749686
Free article.
Clinical Trial.